A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes, Diabetes, vol.54, pp.1763-1769, 2005. ,
Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity, vol.32, pp.488-499, 2010. ,
Dendritic cell control of tolerogenic responses, Immunol. Rev, vol.241, pp.206-227 ,
Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there, Crit. Rev. Immunol, vol.29, pp.87-109, 2009. ,
Endogenous carbon monoxide production in disease, Clin. Biochem, vol.43, pp.1183-1188, 2010. ,
Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation, J. Clin. Invest, vol.117, pp.438-447, 2007. ,
Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice, Cell Cycle, vol.6, pp.567-571, 2007. ,
Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice, Diabetes, vol.56, pp.1240-1247, 2007. ,
Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation, J. Immunol, vol.177, pp.5936-5945, 2006. ,
Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection, Am. J. Transplant, vol.2, pp.581-592, 2002. ,
Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer, Gene Ther, vol.11, pp.701-710, 2004. ,
Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat. Med, vol.4, pp.1073-1077, 1998. ,
Protective genes expressed in endothelial cells: a regulatory response to injury, Immunol. Today, vol.18, pp.483-486, 1997. ,
Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes, Nat. Med, vol.4, pp.1392-1396, 1998. ,
Editorial: heme oxygenase-1 and dendritic cells: what else?, J. Leukoc. Biol, vol.87, pp.185-187, 2010. ,
Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression, Blood, vol.106, pp.1694-1702, 2005. ,
Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity, J. Immunol, vol.182, pp.1877-1884, 2009. ,
Tricarbonyldichlororuthenium (II) dimer (CORM2) activates non-selective cation current in human endothelial cells independently of carbon monoxide releasing, Eur. J. Pharmacol, vol.590, pp.99-104, 2008. ,
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells, Eur. J. Immunol, vol.22, pp.1013-1022, 1992. ,
Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage, J. Immunol, vol.165, pp.202-210, 2000. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01659368
Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets, Am. J. Pathol, vol.170, pp.240-250, 2007. ,
The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation, J. Biol. Chem, vol.278, pp.26983-26991, 2003. ,
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells, Exp. Dermatol, vol.16, pp.661-670, 2007. ,
Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3, J. Immunol, vol.180, pp.7919-7930, 2008. ,
Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells, J. Immunol, vol.176, pp.7180-7188, 2006. ,
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function, J. Exp. Med, vol.197, pp.1141-1151, 2003. ,
Donor HO-1 expression inhibits intimal hyperplasia in unmanipulated graft recipients: a potential role for CD8+ T-cell modulation by carbon monoxide, Transplantation, vol.88, pp.653-661, 2009. ,
Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells, J. Exp. Med, vol.197, pp.643-656, 2003. ,
Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas, J. Biol. Chem, vol.280, pp.27755-27758, 2005. ,
CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virallyinduced autoimmune diabetes, J. Autoimmun, vol.32, pp.70-77, 2009. ,
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs, Cell, vol.99, pp.23-33, 1999. ,
Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice, Eur. J. Immunol, vol.34, pp.548-557, 2004. ,
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis, Nat. Med, vol.8, pp.1414-1420, 2002. ,
,
, N. Engl. J. Med, vol.348, pp.24-32, 2003.
A controlled trial of Natalizumab for relapsing multiple sclerosis, N. Engl. J. Med, vol.348, pp.15-23, 2003. ,
Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation ,
, J. Immunol, vol.172, pp.3553-3563, 2004.
Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276, J. Immunol, vol.179, pp.7840-7851, 2007. ,
Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Free Radic, Biol. Med. 2012, vol.52, pp.794-802 ,
Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease, J. Allergy Clin. Immunol, vol.122, pp.291-298, 2008. ,
Tolerogenic dendritic cells and the quest for transplant tolerance, Nat. Rev. Immunol, vol.7, pp.610-621, 2007. ,
Tolerogenic dendritic cells, Annu. Rev. Immunol, vol.21, pp.685-711, 2003. ,
Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells, Blood, vol.113, pp.6638-6647, 2009. ,
CD4+CD25+Foxp3+ T regulatory cells are not involved in oral desensitization, Int. J. Immunopathol. Pharmacol, vol.23, pp.359-361, 2010. ,
Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy, Eur. J. Immunol, vol.26, pp.130-135, 1996. ,
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo, Immunity, vol.1, pp.327-339, 1994. ,
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein, Nature, vol.379, pp.343-346, 1996. ,
Betacell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, Lancet, vol.358, pp.1749-1753, 2001. ,
Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes, Clin. Exp. Immunol, vol.134, pp.38-45, 2003. ,
Plasmacytoid dendritic cells mediate oral tolerance, Immunity, vol.29, pp.464-475, 2008. ,
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10, Int. Immunol, vol.11, pp.1625-1634, 1999. ,
The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations. J. Autoimmun, vol.22, pp.111-114, 2004. ,
Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance, Proc. Natl ,
, , vol.104, pp.9393-9398, 2007.
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells, Nat. Immunol, vol.10, pp.488-495, 2009. ,
CD8(+) T cell-mediated spontaneous diabetes in neonatal mice, J. Immunol, vol.157, pp.978-983, 1996. ,
, Abbreviations: CO: carbon monoxide · CORM: CO-releasing molecule · gCO: gazeous carbon monoxide · HO: heme oxygenase Full correspondence: Dr. Philippe Blancou, CHU Hotel Dieu, UMR INSERM 1064, vol.30, pp.33-240
, philippe.blancou@gmail.com Current address: Dr. Thomas Simon, INSERM, UMR 1064